Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$32.69
-2.0%
$31.37
$27.07
$40.28
$1.33B1.34250,819 shs243,781 shs
National Vision Holdings, Inc. stock logo
EYE
National Vision
$19.24
+1.2%
$14.19
$9.56
$19.49
$1.52B1.021.82 million shs2.85 million shs
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$5.85
-3.9%
$7.09
$4.54
$10.79
$367.91M0.79605,542 shs773,287 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$21.15
-1.5%
$19.43
$15.75
$53.69
$1.41B1.471.49 million shs1.30 million shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cadre Holdings, Inc. stock logo
CDRE
Cadre
-2.01%-2.29%+11.11%-1.32%-2.16%
National Vision Holdings, Inc. stock logo
EYE
National Vision
+1.21%+3.16%+56.30%+55.54%+36.45%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-3.94%-7.00%-15.22%-35.93%+15.84%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-1.54%-2.31%+21.06%-2.76%-60.02%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cadre Holdings, Inc. stock logo
CDRE
Cadre
3.7015 of 5 stars
2.53.02.50.03.63.31.9
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.7484 of 5 stars
2.22.00.03.34.10.80.0
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
2.223 of 5 stars
3.11.00.00.02.34.20.6
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
4.46 of 5 stars
4.32.00.04.93.01.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cadre Holdings, Inc. stock logo
CDRE
Cadre
3.00
Buy$37.0013.19% Upside
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.44
Hold$17.75-7.74% Downside
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
2.29
Hold$10.1673.63% Upside
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.50
Moderate Buy$37.4777.15% Upside

Current Analyst Ratings Breakdown

Latest TMCI, TNDM, CDRE, and EYE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/22/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$20.00 ➝ $24.00
5/19/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetMarket Perform ➝ Market Perform$13.00 ➝ $19.00
5/12/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$14.00 ➝ $17.00
5/9/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$13.00 ➝ $17.00
5/9/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$13.00 ➝ $21.00
5/9/2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$10.00 ➝ $8.60
5/8/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$18.00 ➝ $20.00
5/8/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$18.00 ➝ $20.00
5/8/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$13.00 ➝ $15.00
5/7/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Buy
5/1/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$58.00 ➝ $59.00
(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$559.81M2.37$1.43 per share22.89$5.25 per share6.23
National Vision Holdings, Inc. stock logo
EYE
National Vision
$1.85B0.82$2.74 per share7.03$10.60 per share1.82
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$210.82M1.75N/AN/A$2.24 per share2.61
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$982.95M1.43N/AN/A$4.81 per share4.40
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$38.64M$0.9539.3824.041.586.34%12.88%6.06%8/8/2025 (Estimated)
National Vision Holdings, Inc. stock logo
EYE
National Vision
-$65.90M-$0.33N/A71.263.27-0.81%3.52%1.39%8/6/2025 (Estimated)
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$49.53M-$0.85N/AN/AN/A-30.33%-51.12%-26.36%8/5/2025 (Estimated)
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$222.61M-$2.78N/AN/AN/A-14.84%-44.19%-11.99%8/7/2025 (Estimated)

Latest TMCI, TNDM, CDRE, and EYE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$0.31-$0.25+$0.06-$0.25$52.07 million$52.57 million
5/7/2025Q1 2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
$0.32$0.34+$0.02$0.18$510.30 million$510.32 million
5/6/2025Q1 2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.13$0.23+$0.10$0.23$121.53 million$130.11 million
4/30/2025Q1 2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.60-$0.67-$0.07-$1.97$220.19 million$234.42 million
3/11/2025Q4 2024
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.48$0.32-$0.16$0.32$170.95 million$175.98 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.381.16%+63.55%40.00%2 Years
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/AN/AN/AN/AN/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
N/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/AN/AN/AN/AN/A

Latest TMCI, TNDM, CDRE, and EYE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/22/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
quarterly$0.09501.29%5/2/20255/2/20255/16/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.65
3.01
1.96
National Vision Holdings, Inc. stock logo
EYE
National Vision
0.30
0.57
0.37
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
0.51
4.12
2.98
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
1.29
2.90
2.32

Institutional Ownership

CompanyInstitutional Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
43.95%
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
84.08%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/A

Insider Ownership

CompanyInsider Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
37.00%
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.70%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
27.72%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
1.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2,24040.66 million25.58 millionOptionable
National Vision Holdings, Inc. stock logo
EYE
National Vision
14,00079.05 million76.94 millionOptionable
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
25062.89 million47.08 millionOptionable
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2,60066.61 million64.23 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cadre stock logo

Cadre NYSE:CDRE

$32.69 -0.68 (-2.04%)
Closing price 05/28/2025 03:59 PM Eastern
Extended Trading
$32.64 -0.05 (-0.16%)
As of 05/28/2025 06:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cadre Holdings, Inc. manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, the Department of Energy, Los Alamos National Laboratories, Waste Isolation Plant, and various foreign government agencies. Cadre Holdings, Inc. was founded in 1964 and is headquartered in Jacksonville, Florida.

National Vision stock logo

National Vision NASDAQ:EYE

$19.24 +0.23 (+1.21%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$19.93 +0.70 (+3.61%)
As of 05/28/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

Treace Medical Concepts stock logo

Treace Medical Concepts NASDAQ:TMCI

$5.85 -0.24 (-3.94%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$5.85 0.00 (0.00%)
As of 05/28/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Tandem Diabetes Care stock logo

Tandem Diabetes Care NASDAQ:TNDM

$21.15 -0.33 (-1.54%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$21.77 +0.62 (+2.93%)
As of 05/28/2025 05:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.